C-307 , 42nd Parliament, 1st session Thursday, December 3, 2015, to Wednesday, September 11, 2019
An Act to amend the Controlled Drugs and Substances Act (tamper resistance and abuse deterrence)
Bill type
Private Member’s Bill
This bill was defeated at second reading in the House of Commons on Wednesday, April 5, 2017
Progress
House of Commons
End of stage activity
Introduction and first reading, Wednesday, September 28, 2016
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Wednesday, September 28, 2016 |
Placed on the order of precedence on Friday, September 30, 2016
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
Thursday, November 17, 2016 |
|
Monday, April 3, 2017 |
|
Wednesday, April 5, 2017 |
Sitting 160
|
Consideration in committee
Not reached
Report stage
Not reached
Third reading
Not reached
First reading
Not reached
Second reading
Not reached
Third reading
Not reached
Details
Recorded votes
House of Commons
Vote 249 — Wednesday, April 5, 2017
- Result:
- Negatived
2nd reading of Bill C-307, An Act to amend the Controlled Drugs and Substances Act (tamper resistance and abuse deterrence)
- Yeas:
- 122
- Nays:
- 160
- Paired:
- 2
- Total:
- 284
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
House of Commons
| Speech date | Speech | Member of Parliament |
|---|---|---|
| Thursday, November 17, 2016 | Sponsor’s speech(Sitting 109) | Kevin Sorenson (Conservative) |
| Thursday, November 17, 2016 | Response speech(Sitting 109) | Kamal Khera (Liberal) |
| Thursday, November 17, 2016 | Response speech(Sitting 109) | Christine Moore (NDP) |
About
Similar bills
No similar bills were introduced during previous sessions or Parliaments
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.